Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11925619 Treatments with nirogacestat

Patent 11925619 was granted and assigned to SpringWorks Therapeutics on March, 2024 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 19 Jun, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 19 Jun, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 12011435 Treatments with nirogacestat
0
Edits on 14 Mar, 2024
"Created via: Patent importer"
Golden AI profile picture
Golden AI
created this topic on 14 Mar, 2024
Edits made to:
Infobox (+16 properties)
Article (+97 characters)
‌

 US Patent 11925619 Treatments with nirogacestat

Article

Patent abstract

The present disclosure relates to improved methods of treatment with nirogacestat.

Infobox
Is a
Patent
Patent
0
Patent Applicant
SpringWorks Therapeutics
SpringWorks Therapeutics
0
Current Assignee
SpringWorks Therapeutics
SpringWorks Therapeutics
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
119256190
Patent Inventor Names
Allison Lim0
Kristin Patterson0
Rex Williams0
Shinta Cheng0
Todd Webster Shearer0
Date of Patent
March 12, 2024
0
Patent Application Number
183618840
Date Filed
July 30, 2023
0
Patent Citations
‌
US Patent 7795447 Imidazole compounds for the treatment of neurodegenerative disorders
0
‌
US Patent 10590087 Solid state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide and uses thereof
0
Patent Primary Examiner
‌
Brian J Davis
0

Find more entities like US Patent 11925619 Treatments with nirogacestat

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo